Background
QueerDoc, PLLC is a telehealth provider that treats patients, including minors, for gender dysphoria and may prescribe puberty blockers and cross-sex hormones. Those drugs are not FDA-approved to treat gender dysphoria, although physicians may generally prescribe approved drugs for off-label uses. QueerDoc also publishes online information about the treatments, pharmacies, insurance claims, and self-injection.
After the President directed the Department of Justice to prioritize investigations into possible Federal Food, Drug, and Cosmetic Act violations involving gender-transition treatments for minors, DOJ issued QueerDoc an administrative subpoena under the Health Insurance Portability and Accountability Act. The subpoena sought personnel, billing, patient, prescription, safety, and business-relationship records. QueerDoc moved to quash, arguing that DOJ was pursuing the improper purpose of eliminating gender-affirming care and, alternatively, that the requests were overbroad and unduly burdensome.
The district court quashed the subpoena in its entirety, finding that DOJ had issued it to advance the administration’s policy objective rather than for a proper investigative purpose. Because that ruling was dispositive, the district court did not decide QueerDoc’s overbreadth and undue-burden objections.
The Court’s Holding
A divided Ninth Circuit reversed. The majority held that DOJ acted within its statutory authority because HIPAA permits administrative subpoenas in investigations of federal health-care offenses, including potential FDCA misbranding violations; DOJ followed the applicable procedures; and the requested materials were relevant to an authorized investigation.
The majority further held that QueerDoc did not carry its heavy burden to establish bad faith or an improper purpose. The Executive Branch’s public opposition to gender-affirming care did not, by itself, overcome the presumption that DOJ regularly exercised its authority. The President may direct DOJ to prioritize lawful investigations that align with broader policy goals.
The court remanded for the district court to consider QueerDoc’s unresolved arguments that the subpoena is overbroad and unduly burdensome. Judge Paez dissented, concluding that DOJ had not adequately established the subpoenaed information’s relevance and that the district court’s finding of bad faith was supported by the record and was not clearly erroneous.
Key Takeaways
- Public statements expressing an administration’s policy opposition to a regulated practice do not alone establish that an otherwise authorized administrative subpoena was issued in bad faith.
- A recipient challenging an administrative subpoena for improper purpose bears a heavy burden and must present specific facts and evidence overcoming the presumption of regularity.
- The decision does not require enforcement of every request as written; the district court must still decide whether the subpoena is overbroad or imposes an undue burden.
Why It Matters
The decision reinforces the limited scope of judicial review in administrative-subpoena proceedings and permits executive agencies to align lawful investigative priorities with presidential policy objectives. Under the majority’s approach, evidence of a controversial policy agenda is not enough without a stronger showing that the particular investigation is pretextual or abusive.
For health-care providers, however, the ruling leaves important protections intact. Courts may still narrow or quash subpoena requests that exceed the authorized investigation’s needs or impose an undue burden, issues the district court must address on remand.